The legacy of Viagra, and its parent company copyright, presents a complex case study for investors. Initially a blockbuster drug, yielding billions in sales , its intellectual property lapse created a wave https://whitebookmarks.com/story21481772/copyright-s-pill-and-pharma-a-risky-investment